Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Patil

Showing results (441-450 of 484) with videos related to

Pageof 49
Sort By:
Plos One|June 10, 2025
Factors associated with chronic opioid use after minimally invasive lung resectionsIsabel Emmerick, Hayley Reddington, Tanmay N Patil, et al.
Life Sciences|May 14, 2022
Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspectivePrasanna J Patil, Shubham S Sutar, Muhammad Usman, et al.
Blood Cell Therapy|December 9, 2024
Sirolimus as add-on therapy to corticosteroids for moderate-severe chronic graft versus host diseaseRitika Sharma, Andrew Pardeep, Renaissa De, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 22, 2024
Oral Cavity Cancers: Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester CommunityN Patil, N Ma, M Mair, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 22, 2024
Authors' Response to Correspondence Re Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester CommunityN Patil, N Ma, M Mair, et al.
Journal of Cancer Research and Therapeutics|February 20, 2024
Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control studyKailas D Datkhile, Satish R Patil, Madhavi N Patil, et al.
ESMO Open|October 22, 2021
Corrigendum to 'Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States': [ESMO Open Volume 6, Issue 5, October 2021, 100252]P Jain, J Gutierrez Bugarin, A Guha, et al.
ESMO Open|August 30, 2021
Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United StatesP Jain, J Gutierrez Bugarin, A Guha, et al.
Bone Marrow Transplantation|August 14, 2019
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myelomaRam V Nampoothiri, Kripa Shanker Kasudhan, Amol N Patil, et al.
Journal of Medicinal Chemistry|September 25, 1997
Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket"X Zhang, J E De Los Angeles, M Y He, et al.
Pageof 49

Showing results (441-450 of 484) with videos related to

Sort By:
Pageof 49
Plos One|June 10, 2025
Factors associated with chronic opioid use after minimally invasive lung resectionsIsabel Emmerick, Hayley Reddington, Tanmay N Patil, et al.
Life Sciences|May 14, 2022
Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspectivePrasanna J Patil, Shubham S Sutar, Muhammad Usman, et al.
Blood Cell Therapy|December 9, 2024
Sirolimus as add-on therapy to corticosteroids for moderate-severe chronic graft versus host diseaseRitika Sharma, Andrew Pardeep, Renaissa De, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 22, 2024
Oral Cavity Cancers: Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester CommunityN Patil, N Ma, M Mair, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 22, 2024
Authors' Response to Correspondence Re Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester CommunityN Patil, N Ma, M Mair, et al.
Journal of Cancer Research and Therapeutics|February 20, 2024
Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control studyKailas D Datkhile, Satish R Patil, Madhavi N Patil, et al.
ESMO Open|October 22, 2021
Corrigendum to 'Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States': [ESMO Open Volume 6, Issue 5, October 2021, 100252]P Jain, J Gutierrez Bugarin, A Guha, et al.
ESMO Open|August 30, 2021
Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United StatesP Jain, J Gutierrez Bugarin, A Guha, et al.
Bone Marrow Transplantation|August 14, 2019
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myelomaRam V Nampoothiri, Kripa Shanker Kasudhan, Amol N Patil, et al.
Journal of Medicinal Chemistry|September 25, 1997
Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket"X Zhang, J E De Los Angeles, M Y He, et al.
Pageof 49